REPL vs UHS · $825.7M cap vs P/E 5.9, rev $15.83B
Replimune Group Inc (REPL) versus Universal Health Services Inc (UHS) — a side-by-side from cached financials, not a winner call.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Universal Health Services Inc (UHS) is a medical care facilities company listed on NYSE.
REPL does not have a complete income-statement cache yet.
Latest reported UHS revenue for 2024-12-31 was $15.83B. Net income was $1.16B. Revenue was up 10.8% from 2023-12-31 to 2024-12-31. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
REPL currently screens at market cap $825.7M. UHS currently screens at market cap $8.55B and trailing P/E 5.9.
Not investment advice. Open the REPL and UHS stock pages for the full models.
Not investment advice.